MedPath

Diagnostic accuracy of urine biomarkers for acute kidney injury after major surgery

Completed
Conditions
acute kidney injury
acute kidney insufficiency
Acute renal failure
acute tubular necrosis
10038430
10017998
Registration Number
NL-OMON42513
Lead Sponsor
Medisch Universitair Ziekenhuis Maastricht
Brief Summary

Trial ended prematurely

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
11
Inclusion Criteria

Patients of 18 years or older.
Patients who undergo elective major general surgery, including the following operations: open aortic reconstruction, major limb amputation [i.e. transfemoral or transtibial amputations, excluding foot amputations], lower limb bypass surgery, colorectal resection, major liver resection [resection of more than one liver segment], pancreatectomy, oesophagectomy and gastrectomy.

Exclusion Criteria

Patients with end-stage renal disease (defined as baseline eGFR *15 mL/min).

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>The primary objective of the proposed study is to determine which urine<br /><br>biomarkers have sufficient diagnostic accuracy (defined as area under receiver<br /><br>oerating characteristic curve greater than 0.70) for early diagnosis of acute<br /><br>kidney injury (defined as an increase in serum creatinine concentration of more<br /><br>than 26 micromol/L or more than 50% of baseline in the first two postoperative<br /><br>days) in patients undergoing major general surgery. Urine biomarkers to be<br /><br>studied are NGAL, KIM-1 and IL-18; further biomarkers of interest will be<br /><br>identified by systematic review and meta-analysis of the scientific literature. </p><br>
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath